Metoclopramide (Maxeran) Oral Dosing
The standard oral dose of metoclopramide is 10 mg taken three to four times daily, administered 30 minutes before meals and at bedtime. 1, 2, 3
Standard Dosing by Indication
Gastroparesis and Nausea/Vomiting
- 10 mg orally 3-4 times daily is the FDA-approved dose for diabetic gastroparesis 3
- Administer 30 minutes before each meal and at bedtime (total 4 doses daily) 2
- Can be titrated up to 5-20 mg per dose for refractory symptoms, maintaining 3-4 administrations daily 1
- Metoclopramide is the only FDA-approved medication for gastroparesis 1
Constipation (as prokinetic agent)
- 10-20 mg orally four times daily when used to promote bowel motility 1
Critical Duration and Safety Limits
European regulatory agencies mandate maximum treatment of 5 days and maximum daily dose of 30 mg to minimize risk of serious neurological complications including tardive dyskinesia and extrapyramidal disorders. 2
This creates a significant clinical dilemma: while the FDA label and American guidelines support chronic use for gastroparesis at 10 mg QID (40 mg/day), European authorities restrict use to 5 days maximum at 30 mg/day maximum. 2 For acute nausea/vomiting, the 5-day limit is reasonable, but gastroparesis often requires longer therapy.
Dose Adjustments
Renal Impairment
- Reduce dose by 50% (start at approximately half the recommended dose) when creatinine clearance is below 40 mL/min 3
- Titrate based on clinical response and tolerability 3
Elderly Patients
- Consider dose reduction in patients over 59 years due to higher risk of adverse effects 2
Key Safety Warnings
Neurological Adverse Effects
- Extrapyramidal symptoms (restlessness, dystonia, akathisia) can occur even at standard doses 4, 5
- Tardive dyskinesia risk increases with duration of use and total cumulative dose 2
- Severe, long-lasting adverse effects have been reported even after short-term low-dose use (as little as 30 mg total over several days), including persistent involuntary movements lasting 10+ months 6
Contraindications
- Avoid in patients with: seizure disorders, pheochromocytoma, GI bleeding, or mechanical obstruction 2
- Do not use if bowel obstruction is suspected 1
Common Side Effects
Clinical Pearls
- Tachyphylaxis may develop: Research shows that chronic oral administration can result in loss of gastrokinetic properties after one month of continuous use 7
- For acute severe symptoms, consider starting with IV/IM administration before transitioning to oral therapy 3
- If acute dystonic reactions occur, treat with diphenhydramine 50 mg IM 3
- The drug should be reserved for debilitating cases after other remedies have failed, given the potential for serious long-lasting neurological effects 6